Elina Urli Hodges

Elina Urli Hodges

Auto-generated profile, based on publicly available information

Elina Urli Hodges

Duke Global Health Innovation Center, Duke Global Health Institute, Durham, North Carolina, United States of America

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 November 2023 in BMJ Global Health
Verified
Journal Article
Open access
PDF file
WMWenhui Mao
Wenhui Mao
RCRianna Cooke
Rianna Cooke
DSDiana Silimperi
Diana Silimperi
EHElina Urli Hodges
Elina Urli Hodges
EOErnesto Ortiz
Ernesto Ortiz
KUKrishna Udayakumar
Krishna Udayakumar
The slow progress in malaria control efforts and increasing challenges have prompted a need to accelerate the research and development (R&D), launch and scaling of effective interventions for malaria elimination. This research, including desk research and key informant interviews, identified the following challenges along the end-to-end scale-up pathway of malaria interventions. Underinvestment in malaria R&D persists, and developers from low-resource settings are not commonly included in the R&D process. Unpredictable or unclear regulatory and policy pathways have been a hurdle. The private sector has not been fully engaged, which results in a less competitive market with few manufacturers, and consequently, a low supply of products. Persistent challenges also exist in the scaling of malaria interventions, such as the fragmentation of malaria programmes. Further efforts are needed to: (1) Strengthen coordination among stakeholders and especially the private sector to inform decisions and mobilise resources. (2) Increase engagement of national stakeholders, particularly those in low-income and middle-income countries, in planning for and implementing R&D, launching and scaling proven malaria interventions. (3) Use financial incentives and other market-shaping strategies to encourage R&D for innovative malaria products and improve existing interventions. (4) Streamline and improve transparency of WHO’s prequalification and guidelines processes to provide timely technical advice and strategies for different settings. (5) Increase effort to integrate malaria services into the broader primary healthcare system. (6) Generate evidence to inform policies on improving access to malaria interventions.

11 September 2023 in BMJ Global Health
Verified
Journal Article
Open access
PDF file
WMWenhui Mao
Wenhui Mao
AZArmand Zimmerman
Armand Zimmerman
EHElina Urli Hodges
Elina Urli Hodges
EOErnesto Ortiz
Ernesto Ortiz
GDGalen Dods
Galen Dods
KUKrishna Udayakumar
Krishna Udayakumar
Over the next decade, millions of deaths could be prevented by increasing access to vaccines in low-income and middle-income countries (LMICs). The COVID-19 pandemic has demonstrated that the research and development (R&D), launch and scale up timelines of vaccines can be drastically shortened. This study compares such timelines for eighteen vaccines and identifies lessons and implications for accelerating the R&D, launch and scale up process for other vaccine candidates. To replicate the rapid R&D process of the COVID-19 vaccines, future vaccine R&D should capitalise on public–private knowledge sharing partnerships to promote technology innovation, establish regional clinical trial centres and data sharing networks to optimise clinical trial efficiency, and create a funding mechanism to support research into novel vaccine platforms that may prove valuable to quickly developing vaccine candidates in future global health emergencies. To accelerate the launch timeline, future efforts to bring safe and efficacious vaccines to market should include LMICs in the decision-making processes of global procurement and delivery alliances to optimise launch in these countries, strengthen the WHO prequalification and Emergency Use Listing programs to ensure LMICs have a robust and transparent regulatory system to rely on, and invest in LMIC regulatory and manufacturing capacity to ensure these countries are vaccine self-sufficient. Lastly, efforts to accelerate scale up of vaccines should include the creation of regional pooled procurement mechanisms between LMICs to increase purchasing power among these countries and an open line of clear communication with the public regarding pertinent vaccine information to combat misinformation and vaccine hesitancy.

10 December 2025 in BMJ Global Health
Verified
Journal Article
Open access
CBCaroline E Boeke
Caroline E Boeke
NHNervine Hamza
Nervine Hamza
CAChukwuemeka Agwuocha
Chukwuemeka Agwuocha
OAOkechukwu Amako
Okechukwu Amako
KDKhamsay Detleuxay
Khamsay Detleuxay
KUKrishna Udayakumar
Krishna Udayakumar
The COVID-19 Treatment QuickStart Consortium worked with governments in seven low- and middle-income countries (LMICs), Ghana, Laos, Malawi, Nigeria, Rwanda, Uganda and Zambia, to implement COVID-19 test-and-treat programmes at 776 health facilities, including training over 5000 staff and facilitating a donation of 11 300 courses of the oral antiviral nirmatrelvir/ritonavir for treatment. This paper describes the process of implementing COVID-19 test-and-treat programmes in each country, provides aggregate programme monitoring data on numbers tested and treated and analyzes programme enablers and challenges. Between country-level programme initiation (Ghana, May 2023; Laos and Malawi, July 2023; Nigeria, June 2023; Rwanda, March 2023; Uganda, September 2023; Zambia, December 2022) and June 2024, a total of 731 970 SARS-CoV-2 tests were conducted. Of 6724 positive tests, a subset were documented to meet eligibility criteria for nirmatrelvir/ritonavir initiation, and 3041 patients were prescribed nirmatrelvir/ritonavir. The largest number of prescriptions was in Zambia. Programme enablers included decentralisation of services; task-shifting from higher to lower health worker cadres; increased access to point of care antigen tests, including self-tests; and the integration of COVID-19 with other health services. Challenges included COVID-19 de-prioritisation at the time of programme rollout, test commodity stockouts and expiries, and dwindling national surveillance efforts. Learnings from rapid initiation and scale-up of COVID-19 test-and-treat programmes in these seven countries can be used to inform future pandemic preparedness strategies in LMICs.

30 December 2025 in medRxiv
Verified
Preprint
Open access
PDF file
EHElina Urli Hodges
Elina Urli Hodges
KCKate Crissman
Kate Crissman
ZCZhanyue Chang
Zhanyue Chang
KEKiara Ekeigwe
Kiara Ekeigwe
JVJoao Ricardo Nickenig Vissoci
Joao Ricardo Nickenig Vissoci
KUKrishna Udayakumar
Krishna Udayakumar
Community health workers are crucial to public health efforts in low– and middle-income countries. Despite their contributions to improving health, they encounter numerous barriers in performing their day-to-day work. Artificial intelligence applications may offer a potential solution to some of these barriers. We examined the implementation of smartphone-based artificial intelligence interventions with community health workers in Uganda, Rwanda, and Nigeria, including how the interventions were developed, how they were used, and successes and challenges of their implementation. This research identified four key considerations for intervention developers, implementing partners, and governments, with respect to implementation of these applications, including: 1) empowering community health workers through professionalization, compensation, and training; 2) understanding the digital ecosystem and aligning with digitization efforts; 3) designing the solution to fit local context, ensuring the development and training of the intervention is applicable to the local environment; and, 4) managing data responsibly with adherence to data privacy and security regulations. This research describes the opportunities for filling gaps in supervisory support, improving diagnosis, and making work more efficient. Providing the community health workforce with digital tools replaces onerous, inefficient paper-based record keeping, enables opportunities for improved supervision, and facilitates decision-making in settings where these workers may be the only point of access to health services and information. Author Summary: Community health workers are often the backbone of the health workforce in low– and middle-income countries. Despite their contributions to community health improvement, they often face barriers and inefficiencies in delivering services. The expansion of smartphone-based artificial intelligence interventions may offer solutions. We examined the implementation of smartphone-based artificial intelligence interventions with community health workers in Uganda, Rwanda, and Nigeria. We found that smartphone-based artificial intelligence applications may help to replace onerous, inefficient paper-based record keeping, enable opportunities for improved supervision, and facilitate decision-making in settings where these individuals may be the only health service providers. This research also identified four key considerations for intervention developers, implementing partners, and governments, with respect to implementation of these applications, including: 1) empowering community health workers through professionalization, compensation, and training; 2) understanding the digital ecosystem and aligning with digitization efforts; 3) designing the solution to fit local context, ensuring the development and training of the intervention is applicable to the local environment; and, 4) managing data responsibly with adherence to data privacy and security regulations.